Recent Publications

Journal manuscripts

  1. Jarvis JN, Harrison TS, Lawn SD, Meintjes G, Wood R, Cleary S. Cost Effectiveness of Cryptococcal Antigen Screening as a Strategy to Prevent HIV-Associated Cryptococcal Meningitis in South Africa. PLoS One. 2013 Jul 19;8(7):e69288.
  2. Lehloenya RJ, Shebe K, Hlela C, Dlamini S, Mankahla A, Lapiner V, Meintjes G, Todd G. Aggressive worsening of Sézary syndrome during early antiretroviral therapy. AIDS. 2013 Mar 27;27(6):1035-6.
  3. Lee SS, Meintjes G, Kamarulzaman A, Leung CC. Management of tuberculosis and latent tuberculosis infection in human immunodeficiency virus-infected persons. Respirology. 2013 Aug;18(6):912-22.
  4. Walker NF, Meintjes G, Wilkinson RJ. HIV-1 and the immune response to TB. Future Virol. 2013 Jan;8(1):57-80.
  5. Jarvis JN, Casazza JP, Stone HH, Meintjes G, Lawn SD, Levitz SM, Harrison TS, Koup RA. The phenotype of the Cryptococcus-specific CD4+ memory T-cell response is associated with disease severity and outcome in HIV-associated cryptococcal meningitis. J Infect Dis. 2013 Jun 15;207(12):1817-28.
  6. van der Plas H, Meintjes G, Schutz C, Goliath R, Myer L, Baatjie D, Wilkinson RJ, Maartens G, Mendelson M. Complications of antiretroviral therapy initiation in hospitalised patients with HIV-associated tuberculosis. PLoS One. 2013;8(2):e54145.
  7. Tadokera R, Wilkinson KA, Meintjes GA, Skolimowska KH, Matthews K, Seldon R, Rangaka MX, Maartens G, Wilkinson RJ. Role of the interleukin 10 family of cytokines in patients with immune reconstitution inflammatory syndrome associated with HIV infection and tuberculosis. J Infect Dis. 2013 Apr;207(7):1148-56.
  8. Marais S, Meintjes G, Pepper DJ, Dodd LE, Schutz C, Ismail Z, Wilkinson KA, Wilkinson RJ. Frequency, severity, and prediction of tuberculous meningitis immune reconstitution inflammatory syndrome. Clin Infect Dis. 2013 Feb;56(3):450-60.
  9. Wilkinson KA, Torok ME, Schwander S, Meintjes G. HIV-associated tuberculosis 2012. Clin Dev Immunol. 2012;2012:950964.
  10. Skolimowska KH, Rangaka MX, Meintjes G, Pepper DJ, Seldon R, Matthews K, Wilkinson RJ, Wilkinson KA. Altered ratio of IFN-γ/IL-10 in patients with drug resistant Mycobacterium tuberculosis and HIV- Tuberculosis Immune Reconstitution Inflammatory Syndrome. PLoS One. 2012;7(10):e46481.
  11. Jarvis JN, Govender N, Chiller T, Park BJ, Longley N, Meintjes G, Bekker LG, Wood R, Lawn SD, Harrison TS. Cryptococcal antigen screening and preemptive therapy in patients initiating antiretroviral therapy in resource-limited settings: a proposed algorithm for clinical implementation. J Int Assoc Physicians AIDS Care (Chic). 2012 Nov-Dec;11(6):374-9.
  12. Meintjes G, Boulle A. Immune reconstitution inflammatory syndrome in a large multicenter cohort study: case definition and comparability. Expert Rev Anti Infect Ther. 2012 Jul;10(7):737-41.
  13. Boyles TH, Black J, Meintjes G, Mendelson M. Failure to eradicate Isospora belli diarrhoea despite immune reconstitution in adults with HIV--a case series. PLoS One. 2012;7(8):e42844.
  14. Fatti G, Meintjes G, Shea J, Eley B, Grimwood A. Improved survival and antiretroviral treatment outcomes in adults receiving community-based adherence support: 5-year results from a multicentre cohort study in South Africa. J Acquir Immune Defic Syndr. 2012 Dec 1;61(4):e50-8.
  15. Meintjes G, Scriven J, Marais S. Management of the immune reconstitution inflammatory syndrome. Curr HIV/AIDS Rep. 2012 Sep;9(3):238-50.
  16. Pepper DJ, Marais S, Bhaijee F, Wilkinson RJ, De Azevedo V, Meintjes G. Assessment at antiretroviral clinics during TB treatment reduces loss to follow-up among HIV-infected patients. PLoS One. 2012;7(6):e37634.
  17. Conesa-Botella A, Meintjes G, Coussens AK, van der Plas H, Goliath R, Schutz C, Moreno-Reyes R, Mehta M, Martineau AR, Wilkinson RJ, Colebunders R, Wilkinson KA. Corticosteroid therapy, vitamin D status, and inflammatory cytokine profile in the HIV-tuberculosis immune reconstitution inflammatory syndrome. Clin Infect Dis. 2012 Oct;55(7):1004-11.
  18. Meintjes G, Skolimowska KH, Wilkinson KA, Matthews K, Tadokera R, Conesa-Botella A, Seldon R, Rangaka MX, Rebe K, Pepper DJ, Morroni C, Colebunders R, Maartens G, Wilkinson RJ. Corticosteroid-modulated immune activation in the tuberculosis immune reconstitution inflammatory syndrome. Am J Respir Crit Care Med. 2012 Aug 15;186(4):369-77.
  19. Lawn SD, Harries AD, Meintjes G, Getahun H, Havlir DV, Wood R. Reducing deaths from tuberculosis in antiretroviral treatment programmes in sub-Saharan Africa. AIDS. 2012 Nov 13;26(17):2121-33.
  20. Wilkinson KA, Meintjes G, Seldon R, Goliath R, Wilkinson RJ. Immunological characterisation of an unmasking TB-IRIS case. S Afr Med J. 2012 Mar 2;102(6):512-7.
  21. Schutz C, Ismail Z, Proxenos CJ, Marais S, Burton R, Kenyon C, Maartens G, Wilkinson RJ, Meintjes G. Burden of antituberculosis and antiretroviral drug-induced liver injury at a secondary hospital in South Africa. S Afr Med J. 2012 Mar 2;102(6):506-11.
  22. Kenyon C, Schrueder N, Ntsekhe M, Meintjes G. Heart failure and cardiogenic shock associated with the TB-immune reconstitution inflammatory syndrome. Cardiovasc J Afr. 2012 Apr 12;23(3):e14-7.
  23. Kenyon CR, Fatti G, Schrueder N, Bonorchis K, Meintjes G. The value of blood culture audits at peripheral hospitals. S Afr Med J. 2012 Mar 7;102(4):224-5.
  24. Jarvis JN, Meintjes G, Rebe K, Williams GN, Bicanic T, Williams A, Schutz C, Bekker LG, Wood R, Harrison TS. Adjunctive interferon-γ immunotherapy for the treatment of HIV-associated cryptococcal meningitis: a randomized controlled trial. AIDS. 2012 Jun 1;26(9):1105-13.
  25. Walker NF, Clark SO, Oni T, Andreu N, Tezera L, Singh S, Saraiva L, Pedersen B, Kelly DL, Tree JA, D'Armiento JM, Meintjes G, Mauri FA, Williams A, Wilkinson RJ, Friedland JS, Elkington PT. Doxycycline and HIV infection suppress tuberculosis-induced matrix metalloproteinases. Am J Respir Crit Care Med. 2012 May 1;185(9):989-97.
  26. Wilkinson KA, Schwander S, Torok ME, Meintjes G. Human immunodeficiency virus-associated tuberculosis. Clin Dev Immunol. 2011;2011:513967.
  27. Govender NP, Chetty V, Roy M, Chiller T, Oladoyinbo S, Maotoe T, Stevens WS, Pinini Z, Spencer D, Venter WD, Jassat W, Cameron D, Meintjes G, Mbengashe T, Pillay Y. Phased implementation of screening for cryptococcal disease in South Africa. S Afr Med J. 2012 Oct 8;102(12):914-7.
  28. Loyse A, Wilson D, Meintjes G, Jarvis JN, Bicanic T, Bishop L, Rebe K, Williams A, Jaffar S, Bekker LG, Wood R, Harrison TS. Comparison of the early fungicidal activity of high-dose fluconazole, voriconazole, and flucytosine as second-line drugs given in combination with amphotericin B for the treatment of HIV-associated cryptococcal meningitis. Clin Infect Dis. 2012 Jan 1;54(1):121-8.
  29. Jarvis JN, Percival A, Bauman S, Pelfrey J, Meintjes G, Williams GN, Longley N, Harrison TS, Kozel TR. Evaluation of a novel point-of-care cryptococcal antigen test on serum, plasma, and urine from patients with HIV-associated cryptococcal meningitis. Clin Infect Dis. 2011 Nov;53(10):1019-23.
  30. Wijewardana I, Jarvis JN, Meintjes G, Harrison TS, Bicanic T. Large volume lumbar punctures in cryptococcal meningitis clear cryptococcal antigen as well as lowering pressure. J Infect. 2011 Dec;63(6):484-6.
  31. Jarvis J, Meintjes G. Cryptococcal meningitis--a neglected killer. S Afr Med J. 2011 Apr;101(4):244-5.
  32. Jarvis JN, Harrison TS, Govender N, Lawn SD, Longley N, Bicanic T, Maartens G, Venter F, Bekker LG, Wood R, Meintjes G. Routine cryptococcal antigen screening for HIV-infected patients with low CD4+ T-lymphocyte counts - time to implement in South Africa? S Afr Med J. 2011 Apr;101(4):232-4.
  33. Kenyon C, Wearne N, Burton R, Meintjes G. The risks of concurrent treatment with tenofovir and aminoglycosides in patients with HIV-associated tuberculosis. South Afr J HIV Med. 2011;12(1):43-45.
  34. Marais S, Pepper DJ, Schutz C, Wilkinson RJ, Meintjes G. Presentation andoutcome of tuberculous meningitis in a high HIV prevalence setting. PLoS One. 2011;6(5):e20077.
  35. Pepper DJ, Marais S, Wilkinson RJ, Bhaijee F, De Azevedo V, Meintjes G. Barriers to initiation of antiretrovirals during antituberculosis therapy in Africa. PLoS One. 2011 May 12;6(5):e19484.
  36. Lawn SD, Meintjes G. Pathogenesis and prevention of immune reconstitution disease during antiretroviral therapy. Expert Rev Anti Infect Ther. 2011Apr;9(4):415-30.
  37. Calligaro G, Meintjes G, Mendelson M. Pulmonary manifestations of the immune reconstitution inflammatory syndrome. Curr Opin Pulm Med. 2011 May;17(3):180-8.
  38. Gideon HP, Wilkinson KA, Rustad TR, Oni T, Guio H, Kozak RA, Sherman DR, Meintjes G, Behr MA, Vordermeier HM, Young DB, Wilkinson RJ. Hypoxia induces an immunodominant target of tuberculosis specific T cells absent from common BCG vaccines. PLoS Pathog. 2010 Dec 23;6(12):e1001237.
  39. Asselman V, Thienemann F, Pepper DJ, Boulle A, Wilkinson RJ, Meintjes G, Marais S. Central nervous system disorders after starting antiretroviral therapy in South Africa. AIDS. 2010 Nov 27;24(18):2871-6.
  40. Haddow LJ, Colebunders R, Meintjes G, Lawn SD, Elliott JH, Manabe YC, Bohjanen PR, Sungkanuparph S, Easterbrook PJ, French MA, Boulware DR; International Network for the Study of HIV-associated IRIS (INSHI). Cryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: proposed clinical case definitions. Lancet Infect Dis. 2010 Nov;10(11):791-802.
  41. Schutz C, Meintjes G, Almajid F, Wilkinson RJ, Pozniak A. Clinical management of tuberculosis and HIV-1 co-infection. Eur Respir J. 2010 Dec;36(6):1460-81.
  42. Jarvis JN, Wainwright H, Harrison TS, Rebe K, Meintjes G. Pulmonary cryptococcosis misdiagnosed as smear-negative pulmonary tuberculosis with fatal consequences. Int J Infect Dis. 2010 Sep;14 Suppl 3:e310-2.
  43. Boulle A, Clayden P, Cohen K, Cohen T, Conradie F, Dong K, Geffen N, Grimwood A, Hurtado R, Kenyon C, Lawn S, Maartens G, Meintjes G, Mendelson M, Murray M, Rangaka M, Sanne I, Spencer D, Taljaard J, Variava E, Venter WD, Wilson D. Prolonged deferral of antiretroviral therapy in the SAPIT trial: did we need a clinical trial to tell us that this would increase mortality? S Afr Med J. 2010 Sep 7;100(9):566, 568, 570-1.
  44. Tadokera R, Meintjes G, Skolimowska KH, Wilkinson KA, Matthews K, Seldon R, Chegou NN, Maartens G, Rangaka MX, Rebe K, Walzl G, Wilkinson RJ. Hypercytokinaemia accompanies HIV-tuberculosis immune reconstitution inflammatory syndrome. Eur Respir J. 2011 May;37(5):1248-59.
  45. Meintjes G, Wilkinson RJ, Morroni C, Pepper DJ, Rebe K, Rangaka MX, Oni T, Maartens G. Randomized placebo-controlled trial of prednisone for paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome. AIDS. 2010 Sep 24;24(15):2381-90.
  46. Meintjes G, Wilkinson RJ. Undiagnosed active tuberculosis in HIV-infected patients commencing antiretroviral therapy. Clin Infect Dis. 2010 Oct 1;51(7):830-2.
  47. Bhaijee F, Wainwright H, Meintjes G, Wilkinson RJ, Todd G, De Vries E, Pepper DJ. Warfarin-induced skin necrosis in HIV-1-infected patients with tuberculosis and venous thrombosis. S Afr Med J. 2010 Jun 1;100(6):372-7.
  48. Jarvis JN, Meintjes G, Williams Z, Rebe K, Harrison TS. Symptomatic relapse of HIV-associated cryptococcal meningitis in South Africa: the role of inadequate secondary prophylaxis. S Afr Med J. 2010 Jun;100(6):378-82.
  49. Wilson D, Meintjes G. Timing of antiretroviral drugs during tuberculosis therapy. N Engl J Med. 2010 Jun 3;362(22):2137.
  50. Schutz C, Boulle A, Stead D, Rebe K, Osler M, Meintjes G. Reduced referral and case fatality rates for severe symptomatic hyperlactataemia in a South African public sector antiretroviral programme: a retrospective observational study. AIDS Res Ther. 2010 May 26;7:13.
  51. Jarvis JN, Meintjes G, Wood R, Harrison TS. Testing but not treating: missed opportunities and lost lives in the South African antiretroviral therapy programme. AIDS. 2010 May 15;24(8):1233-5.
  52. Meintjes G, Wilkinson RJ. Optimum timing of antiretroviral therapy for HIV-infected patients with concurrent serious opportunistic infections. Clin Infect Dis. 2010 Jun 1;50(11):1539-41.
  53. Pepper DJ, Marais S, Wilkinson RJ, Bhaijee F, Maartens G, McIlleron H, De Azevedo V, Cox H, McDermid C, Sokhela S, Patel J, Meintjes G. Clinical deterioration during antituberculosis treatment in Africa: incidence, causes and risk factors. BMC Infect Dis. 2010 Mar 30;10:83.
  54. Jarvis JN, Meintjes G, Harrison TS. Outcomes of cryptococcal meningitis in antiretroviral naïve and experienced patients in South Africa. J Infect. 2010 Jun;60(6):496-8.
  55. Jarvis JN, Meintjes G, Williams A, Brown Y, Crede T, Harrison TS. Adult meningitis in a setting of high HIV and TB prevalence: findings from 4961 suspected cases. BMC Infect Dis. 2010 Mar 15;10:67.
  56. Marais S, Scholtz P, Pepper DJ, Meintjes G, Wilkinson RJ, Candy S. Neuroradiological features of the tuberculosis-associated immune reconstitution inflammatory syndrome. Int J Tuberc Lung Dis. 2010 Feb;14(2):188-96.
  57. Cohen K, Meintjes G. Management of individuals requiring antiretroviral therapy and TB treatment. Curr Opin HIV AIDS. 2010 Jan;5(1):61-9.
  58. de Cherif TK, Schoeman JH, Cleary S, Meintjes GA, Rebe K, Maartens G. Early severe morbidity and resource utilization in South African adults on antiretroviral therapy. BMC Infect Dis. 2009 Dec 15;9:205.
  59. Loyse A, Wainwright H, Jarvis JN, Bicanic T, Rebe K, Meintjes G, Harrison TS. Histopathology of the arachnoid granulations and brain in HIV-associated cryptococcal meningitis: correlation with cerebrospinal fluid pressure. AIDS. 2010 Jan 28;24(3):405-10.
  60. Meintjes G, Rabie H, Wilkinson RJ, Cotton MF. Tuberculosis-associated immune reconstitution inflammatory syndrome and unmasking of tuberculosis by antiretroviral therapy. Clin Chest Med. 2009 Dec;30(4):797-810, x.
  61. Burton R, Gogela N, Rebe K, McNally M, Meintjes G. Cryptococcal immune reconstitution inflammatory syndrome presenting with erosive bone lesions, arthritis and subcutaneous abscesses. AIDS. 2009 Nov 13;23(17):2371-3.
  62. Osler M, Stead D, Rebe K, Meintjes G, Boulle A. Risk factors for and clinical characteristics of severe hyperlactataemia in patients receiving antiretroviral therapy: a case-control study. HIV Med. 2010 Feb;11(2):121-9.
  63. Davies MA, Meintjes G. Assessing the contribution of the immune reconstitution inflammatory syndrome to mortality in developing country antiretroviral therapy programs. Clin Infect Dis. 2009 Sep 15;49(6):973-5.
  64. Wilkinson KA, Seldon R, Meintjes G, Rangaka MX, Hanekom WA, Maartens G, Wilkinson RJ. Dissection of regenerating T-Cell responses against tuberculosis in HIV-infected adults sensitized by Mycobacterium tuberculosis. Am J Respir Crit Care Med. 2009 Oct 1;180(7):674-83.
  65. Bicanic T, Muzoora C, Brouwer AE, Meintjes G, Longley N, Taseera K, Rebe K, Loyse A, Jarvis J, Bekker LG, Wood R, Limmathurotsakul D, Chierakul W, Stepniewska K, White NJ, Jaffar S, Harrison TS. Independent association between rate of clearance of infection and clinical outcome of HIV-associated cryptococcal meningitis: analysis of a combined cohort of 262 patients. Clin Infect Dis. 2009 Sep 1;49(5):702-9.
  66. Marais S, Wilkinson RJ, Pepper DJ, Meintjes G. Management of patients with the immune reconstitution inflammatory syndrome. Curr HIV/AIDS Rep. 2009 Aug;6(3):162-71.
  67. Kevany S, Meintjes G, Rebe K, Maartens G, Cleary S. Clinical and financial burdens of secondary level care in a public sector antiretroviral roll-out setting (G. F. Jooste Hospital). S Afr Med J. 2009 May;99(5):320-5.
  68. Jarvis JN, Boulle A, Loyse A, Bicanic T, Rebe K, Williams A, Harrison TS, Meintjes G. High ongoing burden of cryptococcal disease in Africa despite antiretroviral roll out. AIDS. 2009 Jun 1;23(9):1182-3.
  69. Pepper DJ, Marais S, Maartens G, Rebe K, Morroni C, Rangaka MX, Oni T, Wilkinson RJ, Meintjes G. Neurologic manifestations of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome: a case series. Clin Infect Dis. 2009 Jun 1;48(11):e96-107.
  70. Meintjes G, Lynen L. Prevention and treatment of the immune reconstitution inflammatory syndrome. Curr Opin HIV AIDS. 2008 Jul;3(4):468-76.
  71. Bicanic T, Meintjes G, Rebe K, Williams A, Loyse A, Wood R, Hayes M, Jaffar S, Harrison T. Immune reconstitution inflammatory syndrome in HIV-associated cryptococcal meningitis: a prospective study. J Acquir Immune Defic Syndr. 2009 Jun 1;51(2):130-4.
  72. Bicanic T, Brouwer AE, Meintjes G, Rebe K, Limmathurotsakul D, Chierakul W, Teparrakkul P, Loyse A, White NJ, Wood R, Jaffar S, Harrison T. Relationship of cerebrospinal fluid pressure, fungal burden and outcome in patients with cryptococcal meningitis undergoing serial lumbar punctures. AIDS. 2009 Mar 27;23(6):701-6.
  73. Pepper DJ, Rebe K, Morroni C, Wilkinson RJ, Meintjes G. Clinical deterioration during antitubercular treatment at a district hospital in South Africa: the importance of drug resistance and AIDS defining illnesses. PLoS One. 2009;4(2):e4520.
  74. Meintjes G, Rangaka MX, Maartens G, Rebe K, Morroni C, Pepper DJ, Wilkinson KA, Wilkinson RJ. Novel relationship between tuberculosis immune reconstitution inflammatory syndrome and antitubercular drug resistance. Clin Infect Dis. 2009 Mar 1;48(5):667-76.
  75. Stead D, Osler M, Boulle A, Rebe K, Meintjes G. Severe hyperlactataemia complicating stavudine first-line antiretroviral therapy in South Africa. Antivir Ther. 2008;13(7):937-43.
  76. Meintjes G, Wilkinson KA, Rangaka MX, Skolimowska K, van Veen K, Abrahams M, Seldon R, Pepper DJ, Rebe K, Mouton P, van Cutsem G, Nicol MP, Maartens G, Wilkinson RJ. Type 1 helper T cells and FoxP3-positive T cells in HIV-tuberculosis-associated immune reconstitution inflammatory syndrome. Am J Respir Crit Care Med. 2008 Nov 15;178(10):1083-9.
  77. Meintjes G, Lawn SD, Scano F, Maartens G, French MA, Worodria W, Elliott JH, Murdoch D, Wilkinson RJ, Seyler C, John L, van der Loeff MS, Reiss P, Lynen L, Janoff EN, Gilks C, Colebunders R; International Network for the Study of HIV-associated IRIS. Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings. Lancet Infect Dis. 2008 Aug;8(8):516-23.
  78. Bicanic T, Wood R, Meintjes G, Rebe K, Brouwer A, Loyse A, Bekker LG, Jaffar S, Harrison T. High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients: a randomized trial. Clin Infect Dis. 2008 Jul 1;47(1):123-30.
  79. Meintjes G, Schoeman H, Morroni C, Wilson D, Maartens G. Patient and provider delay in tuberculosis suspects from communities with a high HIV prevalence in South Africa: a cross-sectional study. BMC Infect Dis. 2008 May 25;8:72.
  80. Venter WD, Naicker S, Dhai A, Fabian J, Wadee S, Britz R, Paget G, Meintjes G. Uniquely South African: time to consider offering HIV-positive donor kidneys to HIV-infected renal failure patients? S Afr Med J. 2008 Mar;98(3):182-3.
  81. Dhasmana DJ, Dheda K, Ravn P, Wilkinson RJ, Meintjes G. Immune reconstitution inflammatory syndrome in HIV-infected patients receiving antiretroviral therapy: pathogenesis, clinical manifestations and management. Drugs. 2008;68(2):191-208.
  82. Pepper DJ, Meintjes GA, McIlleron H, Wilkinson RJ. Combined therapy for tuberculosis and HIV-1: the challenge for drug discovery. Drug Discov Today. 2007 Nov;12(21-22):980-9.
  83. Saranchuk P, Boulle A, Hilderbrand K, Coetzee D, Bedelu M, van Cutsem G, Meintjes G. Evaluation of a diagnostic algorithm for smear-negative pulmonary tuberculosis in HIV-infected adults. S Afr Med J. 2007 Jul;97(7):517-23.
  84. McIlleron H, Meintjes G, Burman WJ, Maartens G. Complications of antiretroviral therapy in patients with tuberculosis: drug interactions, toxicity, and immune reconstitution inflammatory syndrome. J Infect Dis. 2007 Aug 15;196 Suppl 1:S63-75.
  85. Bicanic T, Meintjes G, Wood R, Hayes M, Rebe K, Bekker LG, Harrison T. Fungal burden, early fungicidal activity, and outcome in cryptococcal meningitis in antiretroviral-naive or antiretroviral-experienced patients treated with amphotericin B or fluconazole. Clin Infect Dis. 2007 Jul 1;45(1):76-80.
  86. Connell TG, Shey MS, Seldon R, Rangaka MX, van Cutsem G, Simsova M, Marcekova Z, Sebo P, Curtis N, Diwakar L, Meintjes GA, Leclerc C, Wilkinson RJ, Wilkinson KA. Enhanced ex vivo stimulation of Mycobacterium tuberculosis-specific T cells in human immunodeficiency virus-infected persons via antigen delivery by the Bordetella pertussis adenylate cyclase vector. Clin Vaccine Immunol. 2007 Jul;14(7):847-54.
  87. Rangaka MX, Diwakar L, Seldon R, van Cutsem G, Meintjes GA, Morroni C, Mouton P, Shey MS, Maartens G, Wilkinson KA, Wilkinson RJ. Clinical, immunological, and epidemiological importance of antituberculosis T cell responses in HIV-infected Africans. Clin Infect Dis. 2007 Jun 15;44(12):1639-46.
  88. Rangaka MX, Wilkinson KA, Seldon R, Van Cutsem G, Meintjes GA, Morroni C, Mouton P, Diwakar L, Connell TG, Maartens G, Wilkinson RJ. Effect of HIV-1 infection on T-Cell-based and skin test detection of tuberculosis infection. Am J Respir Crit Care Med. 2007 Mar 1;175(5):514-20.
  89. Lehloenya R, Meintjes G. Dermatologic manifestations of the immune reconstitution inflammatory syndrome. Dermatol Clin. 2006 Oct;24(4):549-70, vii.
  90. Bicanic T, Harrison T, Niepieklo A, Dyakopu N, Meintjes G. Symptomatic relapse of HIV-associated cryptococcal meningitis after initial fluconazole monotherapy: the role of fluconazole resistance and immune reconstitution. Clin Infect Dis. 2006 Oct 15;43(8):1069-73.
  91. Schaars CF, Meintjes GA, Morroni C, Post FA, Maartens G. Outcome of AIDS-associated cryptococcal meningitis initially treated with 200 mg/day or 400 mg/day of fluconazole. BMC Infect Dis. 2006 Jul 18;6:118.
  92. Freercks RJ, Mehta U, Stead DF, Meintjes GA. Haemolytic anaemia associated with efavirenz. AIDS. 2006 May 12;20(8):1212-3.
  93. Wilkinson KA, Kon OM, Newton SM, Meintjes G, Davidson RN, Pasvol G, Wilkinson RJ. Effect of treatment of latent tuberculosis infection on the T cell response to Mycobacterium tuberculosis antigens. J Infect Dis. 2006 Feb 1;193(3):354-9.
  94. Bicanic T, Wood R, Bekker LG, Darder M, Meintjes G, Harrison TS. Antiretroviral roll-out, antifungal roll-back: access to treatment for cryptococcal meningitis. Lancet Infect Dis. 2005 Sep;5(9):530-1.
  95. Meintjes G. Case study - a second opinion on management. S Afr J HIV Med, Winter 2008; 55-56.
  96. Asselman V, Meintjes G. A patient with multiple IRIS. S Afr J HIV Med 2007; 28:57-60.
  97. Meintjes G. Structured Treatment Interruptions: Is there an alternative to lifelong HAART? S Afr J HIV Med 2006; 24: 12-15.
  98. Mendelson M, Meintjes G. Increasing the risk of nosocomial transmission of HIV: pitfalls and practices at a busy secondary level hospital with a high burden of HIV. South Afr J Epidemiol Infect 2009; 24(1):8-11.
  99. Meintjes G (Chairperson), Venter WDF, Conradie F, Fabian J, Maartens G, Wilson D (Expert panel members). Guidelines for the Prevention, Diagnosis and Management of NRTI-associated Symptomatic Hyperlactataemia and Lactic Acidosis. Southern African HIV Clinicians Society. SA J HIV Med, March 2006:8-14.
  100. McCarthy K, Meintjes G (Chairpersons), Arthington-Skaggs B, Bicanic T, Cotton M, Chiller T, Govender NP, Harrison TS, Karstaedt AS, Maartens G, Variava E, Venter WDF, Vismer H (Expert panel members), Lalloo D, Larson RA, Sungkanuparph S (Reviewers). Guidelines for the prevention, diagnosis and management of cryptococcal meningitis and disseminated cryptococcosis in HIV-infected patients. Southern African HIV Clinicians Society. S Afr J HIV Med, Spring 2007, 25-35.
  101. Govender NP, Meintjes G (Chairpersons), Bicanic T, Dawood H, Harrison TS, Jarvis JN, Karstaedt AS, Maartens G, McCarthy KM, Rabie H, Variava E, Venter WDF (Expert panel members), Boulware DR, Chiller T, Meya DB, Scriven J (Reviewers). Guideline for the prevention, diagnosis and management of cryptococcal meningitis among HIV-infected persons: 2013 update. Southern African HIV Clinicians Society. S Afr J HIV Med 2013;14(2):76-86.
  102. Meintjes G, Maartens G (Chairpersons), Boulle A, Conradie F, Goemaere E, Hefer E, Johnson D, Mathe M, Moosa Y, Osih R, Rossouw T, van Cutsem G, Variava E, Venter WDF (Expert Panel Members), Spencer D (Reviewer). Guidelines for antiretroviral therapy in adults. Southern African HIV Clinicians Society. S Afr J HIV Med 2012;13(3):114-133.
 

Chapters in books

  1. Meintjes G. HIV-associated Immune Reconstitution Inflammatory Syndrome (IRIS), in: Kumar P, Clark M eds. Kumar & Clark's Clinical Medicine, 8th edition. Saunders Elsevier, 2012: Online Chapter. ISBN: 978-0-7020-4500-4.
  2. Allard D, Meintjes G. HIV and Trauma, in: Oxford Handbook of Trauma, South African edition. Oxford University Press Southern Africa, 2010:374-380. ISBN 978-0-19-598747-8.
  3. French MA, Meintjes G. Disorders of immune reconstitution in patients with HIV infection, in: Infectious Diseases, 3rd Edition. Mosby Elsevier, 2010:975-80. ISBN 978-0-323-04579-7.
  4. Meintjes G. Immune Reconstitution Inflammatory Syndrome, in: Handbook of HIV Medicine, 2nd edition. Oxford University Press Southern Africa, 2009:528-32. ISBN 978-0-19-576135-1.
  5. Meintjes G, Maartens G. Deteriorating tuberculosis in a HIV-infected man despite treatment: immune reconstitution, resistance or drug malabsorption, in: Schaaf HS, Zumla A eds. Tuberculosis. A comprehensive clinical reference. Saunders Elsevier, 2009:852-3. ISBN 978-1-4160-3988-4.
  6. Meintjes GA, Parrish AG. HIV/AIDS, in: Eddleston M, Davidson R, Brent A, Wilkinson R eds. Oxford Handbook of Tropical Medicine, 3rd edition. Oxford University Press, 2008:67-138. ISBN 978-0-19-920409-0.
  7. Soentjens P, Meintjes G, French M, Colebunders R. Immune Reconstitution Inflammatory Syndrome, in: Scheld WM, Hammer SM, Hughes JM eds. Emerging Infections 8. ASM Press, 2008:355-91. ISBN: 978-1-55581-444-1.
  8. Corcoran C, Meintjes G. HIV Virology, in: Temesgen Z, Amoroso A, Gilliam B, Goosby EP, Orenstein R eds. Fundamentals of Global HIV Medicine. IHL Press, 2009:3-11. ISBN: 978-0-9754188-2-6.